AKT1 and cancer: C3G, as a pure compound (250 and 500 μM) and in fruit extracts (0.2% w/v C3G-rich pomegranate juice) inhibits cell proliferation through deactivating MAPK and PI3K/AKT signaling pathways, which are activated by NNK at cancer progression [10,13,32].